Core C: Viral Evolution
Core C: Viral Evolution
批准号:
10425028
负责人:
Jesse D Bloom
金额:
$122.53万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-02 至 2025-08-31
关键词:
2019-nCoVACE2AffectAffinityAmino AcidsAntibodiesAntibody-mediated protectionAntigensBindingBiochemicalCellsCollaborationsComplementCoronavirusDataEngineeringEpitopesEvolutionGoalsImmunityLibrariesMapsMeasurementMeasuresMerbecovirusMonoclonal AntibodiesMutationPropertyProteinsRiskSarbecovirusStructureSystemTechniquesVaccine DesignVaccinesVariantViralViral ProteinsVirusWorkYeastsZoonosesanimal model developmentbasebetacoronaviruscoronavirus vaccinedesignexperimental studyinterestmutantmutation screeningnanoparticleneutralizing antibodyneutralizing vaccinepandemic diseasepolyclonal antibodyprospectivereceptorreceptor bindingresistance mutationsuccesstoolvaccine candidatevirology
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY – CORE C: VIRAL EVOLUTION
The Viral Evolution Core will develop tools to inform the engineering of vaccines that broadly target
coronaviruses that pose a pandemic risk. To do this, the core will use deep mutational scanning to define the
biochemical and functional properties of RBDs and spikes across the full evolutionary span of sarbecoviruses
and merbecoviruses, and systematically map how these proteins are targeted by vaccine-elicited antibody
immunity. In the first aim, we will measure the receptor-binding properties of all known sarbecovirus and
merbecovirus RBDs to identify key strains of interest and inform the development of animal models (Core B:
Virology, Baric). In the second aim, we will develop a system to measure how all mutations to the spikes from
key strains affect cell entry, thereby identifying functionally constrained epitopes to target with vaccines. In the
third aim, we will use the RBD and spike libraries to quantify the binding breadth and robustness to mutations
of vaccine elicited monoclonal and polyclonal antibodies, thereby providing direct functional readouts to rapidly
assess candidate vaccines and inform their further engineering.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Prospectively characterizing the functional and antigenic effects of mutations to viral entry proteins
-
批准号:10593369
-
项目类别:
-
资助金额:$34.36万
-
财政年份:2018
-
负责人:Jesse D Bloom
-
依托单位:
Complete mapping of immune selection from antibodies to HIV
-
批准号:10305599
-
项目类别:
-
资助金额:$9.27万
-
财政年份:2018
-
负责人:Jesse D Bloom
-
依托单位:
Prospectively characterizing the functional and antigenic effects of mutations to viral entry proteins
-
批准号:10237969
-
项目类别:
-
资助金额:$9.59万
-
财政年份:2018
-
负责人:Jesse D Bloom
-
依托单位:
Complete mapping of immune selection from antibodies to HIV
-
批准号:10059172
-
项目类别:
-
资助金额:$48.88万
-
财政年份:2018
-
负责人:Jesse D Bloom
-
依托单位:
Prospectively characterizing the functional and antigenic effects of mutations to viral entry proteins
-
批准号:10471843
-
项目类别:
-
资助金额:$43.95万
-
财政年份:2018
-
负责人:Jesse D Bloom
-
依托单位:
Complete mapping of immune selection from antibodies to HIV
-
批准号:10540820
-
项目类别:
-
资助金额:$8.61万
-
财政年份:2018
-
负责人:Jesse D Bloom
-
依托单位:
Prospectively characterizing the functional and antigenic effects of mutations to viral entry proteins
-
批准号:9790939
-
项目类别:
-
资助金额:$43.95万
-
财政年份:2018
-
负责人:Jesse D Bloom
-
依托单位:
Complete mapping of immune selection from antibodies to HIV
-
批准号:10593442
-
项目类别:
-
资助金额:$39.6万
-
财政年份:2018
-
负责人:Jesse D Bloom
-
依托单位:
High-throughput experiments to guide influenza vaccine strain selection
-
批准号:9219103
-
项目类别:
-
资助金额:$44.31万
-
财政年份:2016
-
负责人:Jesse D Bloom
-
依托单位:
High-throughput experiments to guide influenza vaccine strain selection
-
批准号:9757688
-
项目类别:
-
资助金额:$42.36万
-
财政年份:2016
-
负责人:Jesse D Bloom
-
依托单位:
Mapping epistasis in molecular evolution: the influenza nucleoprotein
-
批准号:9067390
-
项目类别:
-
资助金额:$32.59万
-
财政年份:2012
-
负责人:Jesse D Bloom
-
依托单位:
Mapping epistasis in molecular evolution: the influenza nucleoprotein
-
批准号:8536882
-
项目类别:
-
资助金额:$31.52万
-
财政年份:2012
-
负责人:Jesse D Bloom
-
依托单位:
Mapping epistasis in molecular evolution: the influenza nucleoprotein
-
批准号:8341638
-
项目类别:
-
资助金额:$32.69万
-
财政年份:2012
-
负责人:Jesse D Bloom
-
依托单位:
Mapping epistasis in molecular evolution: the influenza nucleoprotein
-
批准号:8853291
-
项目类别:
-
资助金额:$32.62万
-
财政年份:2012
-
负责人:Jesse D Bloom
-
依托单位:
Mapping epistasis in molecular evolution: the influenza nucleoprotein
-
批准号:8663934
-
项目类别:
-
资助金额:$32.64万
-
财政年份:2012
-
负责人:Jesse D Bloom
-
依托单位:
Constraints on the evolution of influenza oseltamivir resistance
-
批准号:8324193
-
项目类别:
-
资助金额:$10.62万
-
财政年份:2011
-
负责人:Jesse D Bloom
-
依托单位:
Constraints on the evolution of influenza oseltamivir resistance
-
批准号:8090942
-
项目类别:
-
资助金额:$16.2万
-
财政年份:2011
-
负责人:Jesse D Bloom
-
依托单位:
Viral Pathogenesis and Evolution Training Program (VPETP)
-
批准号:10405580
-
项目类别:
-
资助金额:$27.61万
-
财政年份:2009
-
负责人:Jesse D Bloom
-
依托单位:
Viral Pathogenesis and Evolution Training Program (VPETP)
-
批准号:10632041
-
项目类别:
-
资助金额:$28.61万
-
财政年份:2009
-
负责人:Jesse D Bloom
-
依托单位:
国内基金
海外基金
登录
查看更多内容
ACE2/AGXT2信号轴在甲基异柳磷诱导斑马鱼神经发育异常过程中的作用机制研究
-
批准号:JCZRLH202600625
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
ACE2 Ser623磷酸化调控MED1促VSMCs功能损伤在移植血管重构中的作用及机制研究
-
批准号:2026JJ50619
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:翁春艳
-
依托单位:
新型蝙蝠MERS簇冠状病毒HKU5的ACE2细胞受体识别及其分子机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
铁皮石斛通过肠道 ACE2 修复 Trp/GPR142 介
导“肠-胰岛 ”轴血糖调控功能的降糖机制研
究
-
批准号:Y24H280055
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:颜美秋
-
依托单位:
人类ACE2变构抑制剂的成药性及其抗广谱冠状病毒感染的机制研究
-
批准号:82330111
-
项目类别:重点项目
-
资助金额:220万元
-
批准年份:2023
-
负责人:刘刚
-
依托单位:
CAFs来源的外泌体负性调控ACE2促进肾透明细胞癌癌栓新辅助靶向耐药的机制研究
-
批准号:82373169
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:顾良友
-
依托单位:
新型蝙蝠MERS簇冠状病毒HKU5的ACE2受体识别及细胞入侵机制研究
-
批准号:32300137
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:陈静
-
依托单位:
基于外泌体miRNAs介导细胞通讯的大豆ACE2激活肽调控血管稳态机制研究
-
批准号:32302080
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:宋田源
-
依托单位:
基于AT2/ACE2/Ang(1-7)/MAS轴调控心脏-血管-血液系统性重构演变规律研究心衰气虚血瘀证及其益气通脉活血化瘀治法生物学基础
-
批准号:82305216
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:姚骏凯
-
依托单位:
感毒清经ACE2/Ang(1-7)/MasR信号通路抑制PM2.5诱导慢性气道炎症的机制:聚焦肺泡巨噬细胞极化与“胞葬”的表型串扰
-
批准号:82305171
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:吴永灿
-
依托单位: